RECRUITING

Effects of Social Feedback on Intracranial EEG

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to assess the impact of social influence on direct neural recordings in human patients undergoing surgical treatment of epilepsy. 24 patients recruited from the Epilepsy Center at Dartmouth Health Medical Center (DHMC) will undergo electrode implantation throughout the brain to localize epileptogenic zones. Patients will be asked to rate their provider's warmth, competence, and other, similar traits associated with care-competency. They will then complete the picture-induced fear and math portions of the multimodal negative affect task (MNAT) during which iEEG is recorded.

Official Title

Effects of Social Feedback on Intracranial EEG

Quick Facts

Study Start:2023-04-06
Study Completion:2028-02-28
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06975800

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients must be between 18-65 years of age.
  2. * Patients must have a diagnosis of refractory epilepsy undergoing intracranial EEG recording for clinical purposes.
  3. * Patients with a legal guardian will be considered for participation if they are interested and, in the judgment of the research team, they are capable of performing the cognitive tasks required of the study. In those instances, the patient and their legal guardian will both participate in the informed consent process, with the legal guardian signing the consent form.
  1. * Patient has additional neurological condition (such as stroke or dementia) or a psychiatric condition (such as active psychosis or suicidal ideation) and are deemed inappropriate for the study.
  2. * Patients are not able to provide informed consent for any reason (e.g. encephalopathic, experiencing a seizure).

Contacts and Locations

Study Contact

Tor D Wager, PhD
CONTACT
603-646-2196
Tor.D.Wager@Dartmouth.edu

Study Locations (Sites)

Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, 03766
United States

Collaborators and Investigators

Sponsor: Trustees of Dartmouth College

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-06
Study Completion Date2028-02-28

Study Record Updates

Study Start Date2023-04-06
Study Completion Date2028-02-28

Terms related to this study

Additional Relevant MeSH Terms

  • Social Influence
  • Epilepsy